Sort
21,281 grants matching “influenza”
A Novel Systemic and Mucosal Adjuvant for Biodefense
$1,175,233Robert E. Johnston · Global Vaccines, Inc. · U01 · FY2009 · AI
Development of a Multi-species Vaccine for Prevention of Bacterial Otitis Media
$1,175,029Charles C. McOsker · Clarametyx Bioscience, Inc. · R44 · FY2024 · DC
A Nurse-Community Health Worker-Family Partnership Model to Increase COVID-19 Testing in Urban Underserved and Vulnerable Communities
$1,174,281Don C Des Jarlais · New York University · P30 · FY2022 · DA
Identification of Metabolic and Immune Deficits in the Aged Population and Their Restoration to Achieve Youthful Anti-Influenza Vaccine Responsiveness
$1,173,350Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2024 · AI
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infect
$1,172,388Dean Barry Everett · University Of Liverpool · U01 · FY2014 · IP
Recombinant Adenovirus Vector Vaccine Studies
$1,172,046John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Influenza Modeling of Correlates of Protection for Optimal Immune Dynamics and Evolution.
$1,171,832Rafael A. Medina Silva · Emory University · U01 · FY2025 · AI
Regulation of MHC Class II Trafficking in Antigen Presenting Cells
$1,171,368Paul Roche · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Control of Epidemic Influenza
$1,170,764Pedro A Piedra · Baylor College Of Medicine · R01 · FY2006 · AI
Membrane Remodeling in Viral Infection, Parasite Invasion, Apoptosis, and Cancer
$1,169,717Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Influenza Viral Pathogenesis
$1,169,285Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Identification of Metabolic and Immune Deficits in the Aged Population and Their Restoration to Achieve Youthful Anti-Influenza Vaccine Responsiveness
$1,169,078Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2025 · AI
Spirulina oral supplement for enhancing host resilience to virus infection
$1,169,058Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2021 · AT
Vermont Immunobiology / Infectious Diseases Center
$1,167,438Ralph C. Budd · University Of Vermont & St Agric College · P30 · FY2017 · GM
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations
$1,166,528Shuchi Anand · Stanford University · U01 · FY2022 · AI
A Novel Systemic and Mucosal Adjuvant for Biodefense
$1,166,198Robert E. Johnston · Global Vaccines, Inc. · U01 · FY2007 · AI
Vermont Immunobiology / Infectious Diseases Center
$1,165,984Ralph C. Budd · University Of Vermont & St Agric College · P30 · FY2019 · GM
Control of Epidemic Influenza
$1,165,555Baylor College Of Medicine · R01 · FY2005 · AI
Vermont Immunobiology / Infectious Diseases Center
$1,164,819Ralph C. Budd · University Of Vermont & St Agric College · P30 · FY2020 · GM
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,164,520Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
Membrane Remodeling in Viral Infection, Parasite Invasion, Apoptosis, and Cancer
$1,163,820Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,163,165Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Influenza Pathogenesis and Immunology Research Center
$1,162,500Richard W Compans · Emory University · N01 · FY2009 · AI
Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.
$1,162,204Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Innate Immune Antivirals for Biodefense
$1,162,042Michael J Gale · University Of Washington · R01 · FY2013 · AI